Colorectal Cancer Archive

Pap tests, the mainstay screening method to detect cervical cancer, are uncomfortable for some women. In mid-2024, the FDA approved a new self-swab test that can detect human papillomavirus, which causes most cases of cervical cancer. The self-swab test collects cells from the vaginal wall instead of the cervix. Clinicians guide women on how to perform the test in a doctor's office. The self-swab method offers women several benefits, including comfort, accuracy, and potentially greater access to screening.

In 2024, the FDA approved a blood test called Shield as a screening method for colorectal cancer. The test detects 83% of colorectal cancers, but only 13% of precancerous polyps. The FDA approval means that now many insurance plans will pay for the test.

Of the cancer screening tests for men, tests for colon cancer has the strongest evidence for benefit. Men who opt in for prostate cancer screening may have more options beyond PSA blood testing to more accurately identify aggressive cancers. Other screening tests such as full body scans have not been shown to improve outcomes.

A 2024 study suggests that having one or more tattoos may raise a person's risk of developing lymphoma, a type of blood cancer.

Abnormal Pap test results don't always indicate cervical cancer. Most abnormal findings result from the presence of human papillomavirus, or HPV. Typically, the next step is a colposcopy, a test that enables the doctor to look closely at areas that appear abnormal.

While cigarette smoking remains the biggest cause of lung cancer, between 15% and 25% of cases globally occur in people who have never smoked. Lung cancer claims more women's lives than breast and ovarian cancer combined. Risk factors among nonsmokers include age, family history, chronic lung conditions, and exposure to secondhand tobacco smoke, radon, diesel fumes, air pollution, and asbestos. People concerned about their risks should discuss it with their doctor, reduce exposure to lung cancer contributors, and get involved in advocacy efforts.

Screening methods for colorectal cancer continue to evolve. Stool tests are becoming more accurate, and it appears that an experimental blood test might one day provide another effective screening option. The most accurate colorectal cancer screening is a colonoscopy, which allows a doctor to peer inside the colon and rectum, find cancers, and remove potentially precancerous polyps on the spot to prevent future cancer. It's unclear if a stool or blood test will ever be as good for screening as a colonoscopy.